Revenue Breakdown
Composition ()
No data
Revenue Streams
Elanco Animal Health Inc (ELAN) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Pet Health, accounting for 51.8% of total sales, equivalent to $710.00M. Other significant revenue streams include Farm Animal and Contract Manufacturing. Understanding this composition is critical for investors evaluating how ELAN navigates market cycles within the Pharmaceuticals industry.
Profitability & Margins
Evaluating the bottom line, Elanco Animal Health Inc maintains a gross margin of 47.19%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 12.33%, while the net margin is 4.16%. These profitability ratios, combined with a Return on Equity (ROE) of -3.77%, provide a clear picture of how effectively ELAN converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, ELAN competes directly with industry leaders such as AXSM and ARWR. With a market capitalization of $11.81B, it holds a leading position in the sector. When comparing efficiency, ELAN's gross margin of 47.19% stands against AXSM's 91.48% and ARWR's 100.00%. Such benchmarking helps identify whether Elanco Animal Health Inc is trading at a premium or discount relative to its financial performance.
